Saturday, June 12, 2021

Life Sciences Times

532 POSTS0 Comments
https://blstimes.com

BeiGene Presents Long-Term Efficacy and Safety Results from Three Pivotal Trials of BRUKINSA

CAMBRIDGE, Mass. & BEIJING-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced...

U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C

FOSTER CITY, Calif.-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the...

STORY3 Capital Partners Completes Structured Growth Equity Investment in Renew Anchored Dentures

LOS ANGELES-- STORY3 Capital Partners, LLC (“STORY3”), a capital solutions provider founded by veteran deal maker Peter Comisar that is focused exclusively on the...

ElevateBio Announces Margo Roberts, Ph.D. Joins as Scientific Advisor for Company’s Immunotherapy Platform Expansion

CAMBRIDGE, Mass.-- ElevateBio, a cell and gene therapy technology company focused on powering transformative cell and gene therapies, today announced that Margo Roberts, Ph.D.,...

Owl Peak Labs Closes Seed Round

CHARLOTTESVILLE, Va.-- Owl Peak Labs, a life sciences company that develops new screening solutions to detect colorectal cancer, announced today the fully subscribed closure...

Icosavax Appoints Thomas J. Russo Chief Financial Officer

SEATTLE-- Icosavax, Inc. today announced the appointment of Thomas J. Russo as Chief Financial Officer. Mr. Russo brings more than 25 years of diverse...

Anji Pharma Launches Phase 3 Trial for ANJ900 to Treat Type 2 Diabetes Patients with Kidney Disease

CAMBRIDGE, Mass. & SHANGHAI-- Anji Pharma (“Anji”) has initiated a pivotal trial of ANJ900 (delayed-release metformin) in patients with Type 2 diabetes (T2D), including...

Kojin Therapeutics Launches with $60 Million Series A to Develop New Category of Drugs Based on Cell State Biology

CAMBRIDGE, Mass.-- Kojin Therapeutics Inc., the leading company developing new targeted therapeutics based on cell state and ferroptosis biology, today launched with a $60...

SARS-CoV-2 Antibody Test Developed by Promega Receives CE Mark

MADISON, Wis.-- A SARS-CoV-2 antibody test developed by Promega Corporation, the Lumit™ Dx SARS-CoV-2 Immunoassay, has received CE marking and is now available in...

Datavant and Ciox Health Announce Merger, Creating the Largest Neutral and Secure Health Data Ecosystem

SAN FRANCISCO & ALPHARETTA, Ga.-- Datavant, the leader in helping healthcare organizations securely connect their data, and Ciox Health, the leader in clinical data...

TOP AUTHORS

52 POSTS0 Comments
- Advertisment -

Most Read